UBS Upgrade Meets Bullish Options Flow as WCN Pulls Back

Waste Connections is drawing two distinct bullish signals on the same day. UBS upgraded the stock to Buy and lifted its price target. Options traders shifted sharply toward calls. The stock sits at $155.23, down 6% over the past month — making the timing notable.

UBS Turns Bullish

Analyst Jon Windham upgraded WCN to Buy from Neutral this morning. His new target is $200, up from $176. That implies 29% upside from current levels.

Windham's thesis centres on operational discipline. Pricing has been the engine — Q2 saw a 6.6% price increase and 70 basis points of solid waste margin expansion. He acknowledges commodity headwinds from recycled materials and RINs, but sees execution more than offsetting those drags.

Wolfe Research also moved this week. Analyst Nigel Coe assumed coverage on Monday with an Outperform rating and a $204 target. The street consensus stands at Buy, with 19 Buy ratings against just 3 Holds. The mean price target is $202.04 — a 30% premium to where the stock trades now.

Options Market Echoes the Upgrade

The put-call ratio tells the same story from a different angle. WCN's PCR hit 0.55 on Wednesday. The 20-day mean is 0.72. That puts the reading 2.2 standard deviations below average — the most call-heavy positioning seen in weeks.

Traders were adding call exposure even as the stock slipped 0.8% on the day. That kind of divergence — bullish derivatives flow against a falling price — tends to catch attention.

Institutional Holders Adding

Several major holders have been building positions. T. Rowe Price added 545,868 shares in its most recent reporting period. BMO Asset Management added 539,477. RBC Global Asset Management added 602,295. These are significant moves from established managers, not noise.

Converging Context

The borrow market is not a factor here. Availability is effectively uncapped — over 100 million shares are available to borrow against a short interest of roughly 1.5% of free float. Short sellers are not a meaningful pressure point.

Earnings are scheduled for October 21. That gives the analyst upgrade roughly five weeks of runway before the next data point.

---

• Price: $155.23, down 5.9% over one month
• Analyst consensus: Buy | Mean target $202.04 | Implied upside ~30%
• UBS target: $200 (upgraded from Neutral, PT raised from $176)
• Wolfe Research: Outperform, $204 target (initiated Monday)
• PCR: 0.55 vs. 20-day mean of 0.72 (z-score: −2.19)
• SI % FF: ~1.5% — low, not a driver
• Next earnings: October 21